In this episode, we unpack the latest annual performance of Singapore Paincare Holdings Limited for FY2026 to see how this medical group is managing its clinical expansion and operational challenges. We outline the core triumphs and hurdles that defined their corporate journey over the past year, offering vital lessons for clinical businesses.

• Learn how expanding clinic networks and rising patient volume are boosting local revenue streams

• Understand the operational impact of escalating employee costs and goodwill impairment charges on profitability

• Explore upcoming regional partnerships and digital clinic upgrades designed to expand their specialized medical ecosystem

WATCH THE EXPLAINER VIDEO BELOW:

LISTEN TO THE PODCAST BELOW:

BREAKING:

Singapore Paincare Holdings Limited reports a net loss for the financial year ended 30 June 2025 (FY2025). This financial reversal was driven by a confluence of factors, including operational difficulties, non-operating losses, and strategic investments. Management noted that the tightening of claims processes by insurers also impacted revenue.

• The financial outcome was negatively affected by necessary impairment charges, specifically those relating to goodwill and plant and equipment, due to the underperformance of various clinics

• The Group recorded a share of losses from a joint venture and associates, with the joint venture loss primarily caused by a revaluation loss on an investment

• In response to evolving market conditions, the Group undertook a significant rebranding exercise and increased investments in marketing and digital transformation initiatives, including the acquisition of AI technologies

WATCH THE EXPLAINER VIDEO BELOW:

LISTEN TO THE PODCAST BELOW:

There will be an AGM on

Event dates:

For more information, click here: SINGAPORE PAINCARE HOLDINGS LIMITED 2023 AGM